This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Pourshams A, Sepanlou SG, Ikuta KS, Bisignano C, Safiri S, Roshandel G, et al. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2019; 4: 934-47. doi: 10.1016/S2468-1253(19)30347-4PourshamsASepanlouSGIkutaKSBisignanoCSafiriSRoshandelGet al.The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017Lancet Gastroenterol Hepatol201949344710.1016/S2468-1253(19)30347-4702671131648972Open DOISearch in Google Scholar
Morganti AG, Massaccesi M, La Torre G, Caravatta L, Piscopo A, Tambaro R, et al. A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. Ann Surg Oncol 2010; 17: 194-205. doi: 10.1245/S10434-009-0762-4MorgantiAGMassaccesiMLaTorre GCaravattaLPiscopoATambaroRet al.A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancerAnn Surg Oncol20101719420510.1245/S10434-009-0762-419856029Open DOISearch in Google Scholar
Cemazar M, Sersa G. Recent advances in electrochemotherapy. Bioelectricity 2019; 1: 204-13. doi: 10.1089/BIOE.2019.0028CemazarMSersaGRecent advances in electrochemotherapyBioelectricity201912041310.1089/BIOE.2019.0028837029434471824Open DOISearch in Google Scholar
Sersa G, Ursic K, Cemazar M, Heller R, Bosnjak M, Campana LG. Biological factors of the tumour response to electrochemotherapy: review of the evidence and a research roadmap. Eur J Surg Oncol 2021. 8: 1836-46. doi: 10.1016/j.ejso.2021.03.229SersaGUrsicKCemazarMHellerRBosnjakMCampanaLGBiological factors of the tumour response to electrochemotherapy: review of the evidence and a research roadmapEur J Surg Oncol2021818364610.1016/j.ejso.2021.03.22933726951Open DOISearch in Google Scholar
Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874-82. doi: 10.1080/0284186X.2018.1454602GehlJSersaGMatthiessenLWMuirTSodenDOcchiniAet al.Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastasesActa Oncol2018578748210.1080/0284186X.2018.145460229577784Open DOISearch in Google Scholar
Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, et al. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. Eur J Surg Oncol 2018; 44: 651-7. doi: 10.1016/J. EJSO.2018.01.090DjokicMCemazarMPopovicPKosBDezmanRBosnjakMet al.Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot studyEur J Surg Oncol201844651710.1016/J.EJSO.2018.01.090Open DOISearch in Google Scholar
Djokic M, Cemazar M, Bosnjak M, Dezman R, Badovinac D, Miklavcic D, et al. A prospective phase II study evaluating intraoperative electrochemotherapy of hepatocellular carcinoma. Cancers 2020; 12: 1-14. doi: 10.3390/ CANCERS12123778DjokicMCemazarMBosnjakMDezmanRBadovinacDMiklavcic Det al.A prospective phase II study evaluating intraoperative electrochemotherapy of hepatocellular carcinomaCancers20201211410.3390/CANCERS12123778776545433333941Open DOISearch in Google Scholar
Djokic M, Dezman R, Cemazar M, Stabuc M, Petric M, Smid LM, et al. Percutaneous image guided electrochemotherapy of hepatocellular carcinoma: technological advancement. Radiol Oncol 2020; 54: 347-52. doi: 10.2478/RAON-2020-0038DjokicMDezmanRCemazarMStabucMPetricMSmidLMet al.Percutaneous image guided electrochemotherapy of hepatocellular carcinoma: technological advancementRadiol Oncol2020543475210.2478/RAON-2020-0038Open DOISearch in Google Scholar
Edhemovic I, Brecelj E, Cemazar M, Boc N, Trotovsek B, Djokic M, et al. Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study. Eur J Surg Oncol 2020; 46: 1628-33. doi: 10.1016/j. ejso.2020.04.037EdhemovicIBreceljECemazarMBocNTrotovsekBDjokicMet al.Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II studyEur J Surg Oncol20204616283310.1016/j.ejso.2020.04.03732387070Open DOISearch in Google Scholar
Edhemovic I, Brecelj E, Gasljevic G, Marolt Music M, Gorjup V, Mali B, et al. Intraoperative electrochemotherapy of colorectal liver metastases. J Surg Oncol 2014; 110: 320-7. doi: 10.1002/JSO.23625EdhemovicIBreceljEGasljevicGMaroltMusic MGorjupVMaliBet al.Intraoperative electrochemotherapy of colorectal liver metastasesJ Surg Oncol2014110320710.1002/JSO.23625Open DOISearch in Google Scholar
Dežman R, Čemažar M, Serša G, Seliškar A, Erjavec V, Trotovšek B, et al. Safety and feasibility of eElectrochemotherapy of the pancreas in a porcine model. Pancreas 2020; 49: 1168-73. doi: 10.1097/MPA.0000000000001642DežmanRČemažarMSeršaGSeliškarAErjavecVTrotovšekBet al.Safety and feasibility of eElectrochemotherapy of the pancreas in a porcine modelPancreas20204911687310.1097/MPA.000000000000164232898000Open DOISearch in Google Scholar
Girelli R, Prejanò S, Cataldo I, Corbo V, Martini L, Scarpa A, et al. Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation. Radiol Oncol 2015; 49: 147-54. doi: 10.1515/RAON-2015-0013GirelliRPrejanòSCataldoICorboVMartiniLScarpaAet al.Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigationRadiol Oncol2015491475410.1515/RAON-2015-0013Open DOISearch in Google Scholar
Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, et al. Electrochemotherapy in locally advanced pancreatic cancer: preliminary results. Int J Surg 2015; 18: 230-6. doi: 10.1016/J.IJSU.2015.04.055GranataVFuscoRPiccirilloMPalaiaRPetrilloALastoriaSet al.Electrochemotherapy in locally advanced pancreatic cancer: preliminary resultsInt J Surg201518230610.1016/J.IJSU.2015.04.05525917204Open DOISearch in Google Scholar
Granata V, Fusco R, Setola SV, Piccirillo M, Leongito M, Palaia R, et al. Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy. World J Gastroenterol 2017; 23: 4767. doi: 10.3748/ WJG.V23.I26.4767GranataVFuscoRSetolaSVPiccirilloMLeongitoMPalaiaRet al.Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapyWorld J Gastroenterol20171519910.3748/WJG.V23.I26.4767Open DOISearch in Google Scholar
Casadei R, Ricci C, Ingaldi C, Alberici L, Di Marco M, Guido A, et al. Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience. Updates Surg 2020; 72: 1089-96. doi: 10.1007/S13304-020-00782-XCasadeiRRicciCIngaldiCAlbericiLDiMarco MGuidoAet al.Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experienceUpdates Surg20207210899610.1007/S13304-020-00782-XOpen DOISearch in Google Scholar
Spiliopoulos S, Zurlo MT, Casella A, Laera L, Surico G, Surgo A, et al. Current status of non-surgical treatment of locally advanced pancreatic cancer. World J Gastrointest Oncol 2021; 13: 2064-75. doi: 10.4251/WJGO.V13. I12.2064SpiliopoulosSZurloMTCasellaALaeraLSuricoGSurgoAet al.Current status of non-surgical treatment of locally advanced pancreatic cancerWorld J Gastrointest Oncol20211320647510.4251/WJGO.V13.I12.2064Open DOISearch in Google Scholar
Tempero MA, Malafa MP, Chair V, Asbun H, Behrman SW, Benson III AB, et al. NCCN Guidelines Version 2.2015, Pancreatic Adenocarcinoma, American Joint Committee on Cancer (AJCC). Available at: https://www2.tri-kobe.org/nccn/guideline/archive/pancreas2015/english/pancreatic.pdfTemperoMAMalafaMPChairVAsbunHBehrmanSWBensonIII ABet al.NCCN Guidelines Version 2.2015, Pancreatic Adenocarcinoma, American Joint Committee on Cancer (AJCC). Available athttps://www2.tri-kobe.org/nccn/guideline/archive/pancreas2015/english/pancreatic.pdfSearch in Google Scholar
Raymond E, Dahan L, Raoul J-L, Bang Y-J, Borbath I, Lombard-Bohas C, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011; 364: 501-13. doi: 10.1056/NEJMOA1003825RaymondEDahanLRaoulJ-LBangY-JBorbathILombard-BohasCet al.Sunitinib malate for the treatment of pancreatic neuroendocrine tumorsN Engl J Med20113645011310.1056/NEJMOA1003825Open DOISearch in Google Scholar
Carrato Mena A, Grande Pulido E, Guillén-Ponce C. Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinib. Anticancer Drugs 2010; 21(Suppl 1): S3-11. doi: 10.1097/01. CAD.0000361534.44052.C5Carrato MenaAGrande PulidoEGuillén-PonceC.Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: sunitinibAnticancer Drugs201021Suppl 1S31110.1097/01.CAD.0000361534.44052.C520110785Open DOISearch in Google Scholar
Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27-55. doi: 10.1016/0065-2571(84)90007-4ChouTCTalalayPQuantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdv Enzyme Regul198422275510.1016/0065-2571(84)90007-46382953Open DOISearch in Google Scholar
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8. doi: 10.1006/METH.2001.1262LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) MethodMethods200125402810.1006/METH.2001.1262Open DOISearch in Google Scholar
D’onofrio M, Beleù A, de Robertis R. Ultrasound-guided percutaneous procedures in pancreatic diseases: new techniques and applications. Eur Radiol Exp 2019; 3: 2. doi: 10.1186/S41747-018-0081-2D’onofrioMBeleùAde RobertisR.Ultrasound-guided percutaneous procedures in pancreatic diseases: new techniques and applicationsEur Radiol Exp20193210.1186/S41747-018-0081-2634274630671676Open DOISearch in Google Scholar
Martin RCG, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 2013; 20(Suppl 3): S443-9. doi: 10.1245/S10434-012-2736-1MartinRCGMcFarlandKEllisSVelanovichVIrreversible electroporation in locally advanced pancreatic cancer: potential improved overall survivalAnn Surg Oncol201320(Suppl 3)S443910.1245/S10434-012-2736-123128941Open DOISearch in Google Scholar
Petrelli F, Comito T, Ghidini A, Torri V, Scorsetti M and Barni S. Stereotactic body radiation therapy for locally advanced pancreatic cancer: a systematic review and pooled analysis of 19 trials. Int J Radiat Oncol Biol Phys 2017; 97: 313-22. doi: 10.1016/j.ijrobp.2016.10.030.PetrelliFComitoTGhidiniATorriVScorsettiMBarniS. Stereotacticbody radiation therapy for locally advanced pancreatic cancer: a systematic review and pooled analysis of 19 trialsInt J Radiat Oncol Biol Phys2017973132210.1016/j.ijrobp.2016.10.03028068239Open DOISearch in Google Scholar
Campana LG, Miklavčič D, Bertino G, Marconato R, Valpione S, Imarisio I, et al. Electrochemotherapy of superficial tumors - current status: basic principles, operating procedures, shared indications, and emerging applications. Semin Oncol 2019; 46: 173-91. doi: 10.1053/J.SEMINONCOL.2019.04.002CampanaLGMiklavčičDBertinoGMarconatoRValpioneSImarisioIet al.Electrochemotherapy of superficial tumors - current status: basic principles, operating procedures, shared indications, and emerging applicationsSemin Oncol2019461739110.1053/J.SEMINONCOL.2019.04.00231122761Open DOISearch in Google Scholar
Bonferoni MC, Rassu G, Gavini E, Sorrenti M, Catenacci L, Torre ML, et al. Electrochemotherapy of deep-seated tumors: state of art and perspectives as possible “EPR effect enhancer” to improve cancer nanomedicine efficacy. Cancers 2021; 13: 4437. doi: 10.3390/CANCERS13174437BonferoniMCRassuGGaviniESorrentiMCatenacciLTorreMLet al.Electrochemotherapy of deep-seated tumors: state of art and perspectives as possible “EPR effect enhancer” to improve cancer nanomedicine efficacyCancers202113443710.3390/CANCERS13174437843157434503247Open DOISearch in Google Scholar
Bosnjak M, Jesenko T, Markelc B, Janzic L, Cemazar M, Sersa G. PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice. Bioelectrochemistry 2021; 140: 107832. doi: 10.1016/J.BIOELECHEM.2021.107832BosnjakMJesenkoTMarkelcBJanzicLCemazarMSersaGPARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in miceBioelectrochemistry202114010783210.1016/J.BIOELECHEM.2021.107832Open DOISearch in Google Scholar
Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 2000; 11: 201-8. doi: 10.1097/00001813-200003000-00008JaroszeskiMJDangVPottingerCHickeyJGilbertRHellerRToxicity of anticancer agents mediated by electroporation in vitroAnticancer Drugs200011201810.1097/00001813-200003000-0000810831279Open DOISearch in Google Scholar
Ursic K, Kos S, Kamensek U, Cemazar M, Scancar J, Bucek S, et al. Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma. Bioelectrochemistry 2018; 119:161-71. doi: 10.1016/J.BIOELECHEM.2017.09.009UrsicKKosSKamensekUCemazarMScancarJBucekSet al.Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanomaBioelectrochemistry20181191617110.1016/J.BIOELECHEM.2017.09.009Open DOISearch in Google Scholar
Michel O, Kulbacka J, Saczko J, Mączyńska J, Blasiak P, Rossowska J, et al. Electroporation with cisplatin against metastatic pancreatic cancer: in vitro study on human primary cell culture. BioMed Res Int 2018; 2018: 7364539. doi: 10.1155/2018/7364539MichelOKulbackaJSaczkoJMączyńskaJBlasiakPRossowskaJet al.Electroporation with cisplatin against metastatic pancreatic cancer: in vitro study on human primary cell cultureBioMed Res Int20182018736453910.1155/2018/7364539588443829750170Open DOISearch in Google Scholar
Fernandes P, O’Donovan TR, McKenna SL and Forde PF: Electrochemotherapy causes caspase-independent necrotic-like death in pancreatic cancer cells. Cancers 2019; 11: 1177. doi: 10.3390/cancers11081177FernandesPO’DonovanTRMcKennaSLFordePFElectrochemotherapy causes caspase-independent necrotic-like death in pancreatic cancer cellsCancers201911117710.3390/cancers11081177672153231416294Open DOISearch in Google Scholar
Dhuriya YK, Sharma D. Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflammation 2018; 15: 199. doi: 10.1186/S12974-018-1235-0.DhuriyaYKSharmaDNecroptosis: a regulated inflammatory mode of cell deathJ Neuroinflammation20181519910.1186/S12974-018-1235-0.Open DOISearch in Google Scholar
Ali MS, Gill KS, Saglio G, Cilloni D, Soden DM, Forde PF. Expressional changes in stemness markers post electrochemotherapy in pancreatic cancer cells. Bioelectrochemistry 2018; 122: 84-92. doi: 10.1016/J. BIOELECHEM.2018.03.009AliMSGillKSSaglioGCilloniDSodenDMFordePFExpressional changes in stemness markers post electrochemotherapy in pancreatic cancer cellsBioelectrochemistry2018122849210.1016/J. BIOELECHEM.2018.03.009Open DOISearch in Google Scholar
Tran Cao HS, Bouvet M, Kaushal S, Keleman A, Romney E, Kim G, et al. Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. Mol Cancer Ther 2010; 9: 2068-78. doi: 10.1158/1535-7163.MCT-10-0201TranCao HSBouvetMKaushalSKelemanARomneyEKimGet al.Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancerMol Cancer Ther2010920687810.1158/1535-7163.MCT-10-0201438308520606044Open DOISearch in Google Scholar
Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, et al. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer 2005; 104: 427-38. doi: 10.1002/ CNCR.21145WeyJSFanFGrayMJBauerTWMcCartyMFSomcioRet al.Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell linesCancer20051044273810.1002/CNCR.21145Open DOISearch in Google Scholar